The presence of IBD among patients with axSpA was not linked to an increased risk for active axSpA or radiographic progression.
Investor's Business Daily on MSN
Nvidia, IBD Stock Of The Day, Seen Unscathed By OpenAI's AMD Deal
Nvidia is seen largely unaffected by major customer OpenAI securing secondary supply deals with other AI chip vendors.
Subcutaneous vedolizumab dose intensification restored steroid-free clinical response in approximately one-third of patients with IBD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback